1-6 of 6
daunorubicin
Close
Sort by
Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.
https://doi.org/10.1182/hematology.2019000059
Published: 2019
Journal Articles

Cytotoxic therapy in acute myeloid leukemia: not quite dead yet

Laura C. Michaelis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 51–62.
https://doi.org/10.1182/asheducation-2018.1.51
Published: 2018
Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.
https://doi.org/10.1182/asheducation-2017.1.54
Published: 2017
Journal Articles

Treatment of acute myeloid leukemia: are we making progress?

Alan K. Burnett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 1–6.
https://doi.org/10.1182/asheducation.V2012.1.1.3797038
Published: 2012
Journal Articles

New Trends in the Standard of Care for Initial Therapy of Acute Myeloid Leukemia

Hugo F. Fernandez
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 56–61.
https://doi.org/10.1182/asheducation-2010.1.56
Published: 2010
Journal Articles

New Strategies for the Treatment of Acute Myeloid Leukemia Including Antibodies and Other Novel Agents

Martin S. Tallman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 143–150.
https://doi.org/10.1182/asheducation-2005.1.143
Published: 2005